Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells

Shashwat Malhotra; Sakshi Balwani; Ashish Dhawan; Brajendra K. Singh; Sarvesh Kumar; Rajesh Thimmulappa; Shyam Biswal; Carl E. Olsen; Erik Van Der Eycken; Ashok K. Prasad; Balaram Ghosh; Virinder S. Parmar

doi:10.1039/c0md00262c

Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells

Shashwat Malhotra, Sakshi Balwani, Ashish Dhawan, Brajendra K. Singh, Sarvesh Kumar, Rajesh Thimmulappa, Shyam Biswal, Carl E. Olsen, Erik Van Der Eycken, Ashok K. Prasad, Balaram Ghosh, Virinder S. Parmar

Bloomberg School of Public Health

Research output: Contribution to journal › Article

Abstract

Novel N-protected derivatives of substituted isatins have been synthesized and evaluated for their potency in inhibiting TNF-α-induced ICAM-1 activity on human endothelial cells as a marker for anti-inflammatory activity. Compound 3p was found to be most potent in inhibiting the ICAM-1 expression in a concentration- and time-dependent manner. The structure-activity relationship of these compounds in inhibiting ICAM-1 expression activity is elucidated in the present study.

Original language	English (US)
Pages (from-to)	743-751
Number of pages	9
Journal	MedChemComm
Volume	2
Issue number	8
DOIs	https://doi.org/10.1039/c0md00262c
State	Published - Aug 1 2011

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Organic Chemistry

Access to Document

10.1039/c0md00262c

Fingerprint Dive into the research topics of 'Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells'. Together they form a unique fingerprint.

Cite this

Malhotra, S., Balwani, S., Dhawan, A., Singh, B. K., Kumar, S., Thimmulappa, R., Biswal, S., Olsen, C. E., Van Der Eycken, E., Prasad, A. K., Ghosh, B., & Parmar, V. S. (2011). Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells. MedChemComm, 2(8), 743-751. https://doi.org/10.1039/c0md00262c

Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells. / Malhotra, Shashwat; Balwani, Sakshi; Dhawan, Ashish; Singh, Brajendra K.; Kumar, Sarvesh; Thimmulappa, Rajesh; Biswal, Shyam; Olsen, Carl E.; Van Der Eycken, Erik; Prasad, Ashok K.; Ghosh, Balaram; Parmar, Virinder S.

In: MedChemComm, Vol. 2, No. 8, 01.08.2011, p. 743-751.

Research output: Contribution to journal › Article

Malhotra, S, Balwani, S, Dhawan, A, Singh, BK, Kumar, S, Thimmulappa, R, Biswal, S, Olsen, CE, Van Der Eycken, E, Prasad, AK, Ghosh, B & Parmar, VS 2011, 'Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells', MedChemComm, vol. 2, no. 8, pp. 743-751. https://doi.org/10.1039/c0md00262c

Malhotra, Shashwat ; Balwani, Sakshi ; Dhawan, Ashish ; Singh, Brajendra K. ; Kumar, Sarvesh ; Thimmulappa, Rajesh ; Biswal, Shyam ; Olsen, Carl E. ; Van Der Eycken, Erik ; Prasad, Ashok K. ; Ghosh, Balaram ; Parmar, Virinder S. / Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells. In: MedChemComm. 2011 ; Vol. 2, No. 8. pp. 743-751.

@article{9d878eba47e7423f86097c9983aec62b,

title = "Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells",

abstract = "Novel N-protected derivatives of substituted isatins have been synthesized and evaluated for their potency in inhibiting TNF-α-induced ICAM-1 activity on human endothelial cells as a marker for anti-inflammatory activity. Compound 3p was found to be most potent in inhibiting the ICAM-1 expression in a concentration- and time-dependent manner. The structure-activity relationship of these compounds in inhibiting ICAM-1 expression activity is elucidated in the present study.",

author = "Shashwat Malhotra and Sakshi Balwani and Ashish Dhawan and Singh, {Brajendra K.} and Sarvesh Kumar and Rajesh Thimmulappa and Shyam Biswal and Olsen, {Carl E.} and {Van Der Eycken}, Erik and Prasad, {Ashok K.} and Balaram Ghosh and Parmar, {Virinder S.}",

year = "2011",

month = aug,

day = "1",

doi = "10.1039/c0md00262c",

language = "English (US)",

volume = "2",

pages = "743--751",

journal = "MedChemComm",

issn = "2040-2503",

publisher = "Royal Society of Chemistry",

number = "8",

}

TY - JOUR

T1 - Synthesis and biological activity evaluation of N-protected isatin derivatives as inhibitors of ICAM-1 expression on human endothelial cells

AU - Malhotra, Shashwat

AU - Balwani, Sakshi

AU - Dhawan, Ashish

AU - Singh, Brajendra K.

AU - Kumar, Sarvesh

AU - Thimmulappa, Rajesh

AU - Biswal, Shyam

AU - Olsen, Carl E.

AU - Van Der Eycken, Erik

AU - Prasad, Ashok K.

AU - Ghosh, Balaram

AU - Parmar, Virinder S.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Novel N-protected derivatives of substituted isatins have been synthesized and evaluated for their potency in inhibiting TNF-α-induced ICAM-1 activity on human endothelial cells as a marker for anti-inflammatory activity. Compound 3p was found to be most potent in inhibiting the ICAM-1 expression in a concentration- and time-dependent manner. The structure-activity relationship of these compounds in inhibiting ICAM-1 expression activity is elucidated in the present study.

AB - Novel N-protected derivatives of substituted isatins have been synthesized and evaluated for their potency in inhibiting TNF-α-induced ICAM-1 activity on human endothelial cells as a marker for anti-inflammatory activity. Compound 3p was found to be most potent in inhibiting the ICAM-1 expression in a concentration- and time-dependent manner. The structure-activity relationship of these compounds in inhibiting ICAM-1 expression activity is elucidated in the present study.

UR - http://www.scopus.com/inward/record.url?scp=79961146105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961146105&partnerID=8YFLogxK

U2 - 10.1039/c0md00262c

DO - 10.1039/c0md00262c

M3 - Article

AN - SCOPUS:79961146105

VL - 2

SP - 743

EP - 751

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 8

ER -